Yondelis . El Instituto Frances Bergonié Inicia ensayo Clinico de Fase I - II . El Centro Léon Bérard y en el Instituto Gustave Roussy tambien realizaran dicho ensayo .

Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide (CP) in Patients With Advanced Pretreated Soft-tissue Sarcomas. A Phase I/II Study From the French Sarcoma Group.

View of NCT02805725 on 2016_06_19 .

ClinicalTrials Identifier : NCT02805725 .

Updated : 2016_06_19 .

Administrative Data :

Organization name : Institut Bergonié .

Organization study ID : IB 2015-04 .

Sponsor : Institut Bergonié .

Collaborator : PharmaMar .

Health Authority :
France : Agence Nationale de Sécurité du Médicament et des produits de santé .

...